Protara Therapeutics, Inc. Increase (Decrease) in Other Receivables
Protara Therapeutics, Inc. (TARA) reported Increase (Decrease) in Other Receivables of -$17.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2020-03-20
- Protara Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2019-12-31 was -$7.00K.
- Protara Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2019-09-30 was -$5.00K, a 171.43% decline year-over-year.
- Protara Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2019-06-30 was -$20.00K.
- Protara Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2019-03-31 was $15.00K.
- Protara Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2019 was -$17.00K.
- Protara Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2018 was -$49.00K, a 206.52% decline from fiscal 2017.
- Protara Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2017 was $46.00K, a 76.92% increase from fiscal 2016.
- Protara Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2016 was $26.00K, a 18.75% decline from fiscal 2015.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$12.00K derived: sum of 2 quarters · filed 2020-03-20 | -$32.00K derived: sum of 3 quarters · filed 2020-03-20 | -$17.00K 10-K · filed 2020-03-20 |
| 2019-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$25.00K derived: sum of 2 quarters · filed 2019-10-31 | -$10.00K 10-Q · filed 2019-10-31 | -$62.00K derived: sum of 4 quarters · filed 2020-03-20 |
| 2019-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$5.00K 10-Q · filed 2019-08-07 | -$57.00K derived: sum of 3 quarters · filed 2020-03-20 | -$50.00K derived: sum of 4 quarters · filed 2020-03-20 |
| 2019-03-31 | $15.00K 10-Q · filed 2019-05-08 | -$37.00K derived: sum of 2 quarters · filed 2020-03-20 | -$30.00K derived: sum of 3 quarters · filed 2020-03-20 | -$30.00K derived: sum of 4 quarters · filed 2020-03-20 |
| 2018-12-31 | -$52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$45.00K derived: sum of 2 quarters · filed 2020-03-20 | -$45.00K derived: sum of 3 quarters · filed 2020-03-20 | -$49.00K 10-K · filed 2020-03-20 |
| 2018-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $7.00K derived: sum of 2 quarters · filed 2019-10-31 | $3.00K 10-Q · filed 2019-10-31 | -$24.00K derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$4.00K 10-Q · filed 2019-08-07 | -$31.00K derived: sum of 3 quarters · filed 2019-08-07 | $30.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | -$4.00K 10-Q · filed 2019-05-08 | -$31.00K derived: sum of 2 quarters · filed 2019-05-08 | $30.00K derived: sum of 3 quarters · filed 2019-05-08 | $27.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $34.00K derived: sum of 2 quarters · filed 2019-03-13 | $31.00K derived: sum of 3 quarters · filed 2019-03-13 | $46.00K 10-K · filed 2019-03-13 |
| 2017-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $58.00K derived: sum of 2 quarters · filed 2018-11-07 | $73.00K 10-Q · filed 2018-11-07 | $145.00K derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $12.00K 10-Q · filed 2018-08-07 | $84.00K derived: sum of 3 quarters · filed 2019-03-13 | $12.00K derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-03-31 | $15.00K 10-Q · filed 2017-05-10 | $87.00K derived: sum of 2 quarters · filed 2019-03-13 | $15.00K derived: sum of 3 quarters · filed 2019-03-13 | $15.00K derived: sum of 4 quarters · filed 2019-03-13 |
| 2016-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $0.00 derived: sum of 2 quarters · filed 2019-03-13 | $0.00 derived: sum of 3 quarters · filed 2019-03-13 | $26.00K 10-K · filed 2019-03-13 |
| 2016-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$72.00K derived: sum of 2 quarters · filed 2017-11-07 | -$46.00K 10-Q · filed 2017-11-07 | -$228.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $26.00K 10-Q · filed 2017-08-07 | -$156.00K derived: sum of 3 quarters · filed 2018-03-14 | -$140.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $26.00K 10-Q · filed 2017-05-10 | -$156.00K derived: sum of 2 quarters · filed 2018-03-14 | -$140.00K derived: sum of 3 quarters · filed 2018-03-14 | -$247.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | -$182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$166.00K derived: sum of 2 quarters · filed 2018-03-14 | -$273.00K derived: sum of 3 quarters · filed 2018-03-14 | $32.00K 10-K · filed 2018-03-14 |
| 2015-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$91.00K derived: sum of 2 quarters · filed 2016-11-07 | $214.00K 10-Q · filed 2016-11-07 | |
| 2015-06-30 | -$107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $198.00K 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $305.00K 10-Q · filed 2016-05-09 | |||
| 2014-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $28.00K derived: sum of 2 quarters · filed 2015-11-12 | $13.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $1.00K 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | -$15.00K 10-Q · filed 2015-05-13 | |||
| 2013-09-30 | -$15.00K 10-Q · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |